Tagged with ERS

access In modern terms, Peru’s healthcare system was largely underdeveloped for many years; but the economic fortune that Peru has experienced in more recent years has allowed for a significant overhaul and reform of the system. However, the road to health reform is rocky. Peruvian Congressman Gustavo Rondón, secretary for the…

universal healthcare Healthcare is one of the next items on President Peña Nieto’s busy agenda. The objective: moving Mexico towards universal healthcare coverage. The initiative was started at the beginning of 2000 by the previous government with the objective of ensuring in the long term that “any Mexican – employed or unemployed…

innovation The Korea Drug Research Association (KDRA) was founded in 1986 to represent local pharmaceutical companies in their mission for global drug development. Kang-Choo Lee, president of KDRA, discusses the current scenario for local companies and outlines his ambitions for making Korea a global hub for innovation.   Since we met…

MSD Don Hyun, president of MSD Korea, shares his vision to bring Korean pharmaceutical companies to the global stage and to bring a locally produced drug to blockbuster status in the coming years.   2014 represents MSD’s 20th anniversary in Korea. How did the affiliate commemorate the occasion? In the current…

generics  Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded generic market and their plans for growth in the future.   You are currently the Vice President of CAPGEN; could you please tell us a bit about…

Monash University Professor Kenneth K. C. Lee, Head of the School of Pharmacy at Monash University Malaysia, discusses the institution’s position as a hub for health economics in the Asia Pacific region and explains the factors that will make the university a pharmaceutical leader.   There is a lot of competition in…

university The executive director of Latin America’s largest plasma fractionation plant, a publicly-funded laboratory within the 400 year old National University of Cordoba, discusses the organization’s social responsibility as a provider and leader for plasma derived therapies in the region, and their exciting pipeline of innovative biotech products.     How does Hemoderivados’s…

partnerships “We are glad to host, together with ETIF, an event bringing forward pharma technologies to Argentinian patients. We hope this collaboration with ETIF will be the first of many” – Ines Nandin, Publisher, PharmaBoardroom The eighth biennial Pharmaceutical Industry Technology Event (ETIF) took recently took place in Buenos Aires, running from…

cardiology The general manager of Argentia weighs up the factors that have led to his company consolidating its different business lines and becoming one of the fastest growing companies in Argentina.   What was your main objective upon joining Argentia? In 1995, Argentia was acquired by BMS and was sold to…

clinical trials Klinsel’s CEO discusses the company’s ambitions of growth in a very competitive CRO market and stresses that local experience is truly a distinguishing factor and this is why they are already partnering and performing trials for one of the country’s largest local manufacturers.     Klinsel was appointed last year…

association Elmer Torres Cortes is General Manager of the Industrial Association of Pharmaceutical Laboratories (ASILFA) that was created to defend the interests of the generic and local manufacturers. Cortes speaks about the developments of the Chilean pharmaceutical industry.   What are the main drivers and challenges for the Chilean pharmaceutical industry…

mergers The global pharmaceutical sector continues to witness significant mergers and acquisitions activity, with 122 M&A deals completed in 2013. This trend has continued due to several multi-billion dollar deals around the world in 2014, which is already recorded the busiest year for healthcare acquisitions. In Chile, the dealmaking sweeping started in December 2013…